alert-icon
Bare begrenset materiale er tilgjengelig på det valgte språket.  Alt innhold er tilgjengelig på det globale nettstedet.
  • Løsninger
  • Karrierer
  • Investorer

Om Wolters Kluwer

Wolters Kluwer er en global leverandør av informasjon, programvareløsninger og tjenester for klinikere, helsearbeidere, advokater, skatterådgivere, finans, revisjon, risikostyring, og compliance.

Om oss
  • Organisasjonen vår
  • Strategi
  • Om Wolters Kluwer
Ekspertinnsikt
  • All ekspertinnsikt
  • Helse
  • Skatt og økonomi
  • ESG
  • Finans
  • Forskriftssamsvar
  • Juridisk
Få hjelp
  • Kontakt oss
  • Login
  • eShop & Bookstores
  • Vis løsningsliste
  • Mediasenter
  • Nyheter og pressemeldinger
  • Løsninger
  • Karrierer
  • Investorer
PrimaryNav Button
Wolters Kluwer Logo
Search
    No Suggestion
    WK logo
    Besøk vår globale side på engelsk eller velg et annet sted eller språk nedenfor
    • Amerika
    • Europa
    • Asien & Stillahavsregionen
    Brazil
    Hjem:
    • Portugisisk
    Canada
    Hjem:
    • Engelsk
    • Fransk
    Latin-Amerika
    Hjem:
    • Spansk
    USA
    Hjem:
    • Engelsk
    Nåværende Side:
    • Engelsk
    Belgia
    Hjem:
    • Nederlandsk
    • Fransk
    Tsjekkia
    Hjem:
    • Tsjekkisk
    Danmark
    Hjem:
    • Dansk
    Frankrike
    Hjem:
    • Fransk
    Tyskland
    Hjem:
    • German
    Ungarn
    Hjem:
    • Ungarsk
    Italia
    Hjem:
    • Italiensk
    Netherlands
    Hjem:
    • Nederlandsk
    Norge
    Hjem:
    • Norsk
    Polen
    Hjem:
    • Polsk
    Portugal
    Hjem:
    • Portugisisk
    Romania
    Hjem:
    • Rumensk
    Slovakia
    Hjem:
    • Slovakisk
    Spania
    Hjem:
    • Spansk
    Sverige
    Hjem:
    • Svensk
    Storbritannia
    Hjem:
    • Engelsk
    Australia
    Hjem:
    • Engelsk
    Kina
    Hjem:
    • Forenklet Kinesisk
    Hong Kong
    Hjem:
    • Engelsk
    India
    Hjem:
    • Engelsk
    Japan
    Hjem:
    • Japansk
    Malaysia
    Hjem:
    • Engelsk
    New Zealand
    Hjem:
    • Engelsk
    Filippinene
    Hjem:
    • Engelsk
    Singapore
    Hjem:
    • Engelsk
    Sør-Korea
    Hjem:
    • Engelsk
    Taiwan
    Hjem:
    • Engelsk
    Thailand
    Hjem:
    • Engelsk
    Vietnam
    Hjem:
    • Engelsk
    Primary Navigation
    • Helse

      Pålitelig klinisk teknologi og bevisbaserte løsninger som gir effektiv beslutningstaking og effektive resultater på tvers av helsesektoren. Spesialisert på klinisk effektivitet, opplæring, forskning og sikkerhet.

      Oversikt over helse
      Løsninger
      • UpToDateBransjeledende støtte for kliniske beslutninger
      • OvidVerdens mest pålitelige plattform for medisinsk forskning
      • UpToDate LexidrugBevisbaserte referanseløsninger for legemidler
      • Ovid SynthesisArbeidsflytløsning for forbedringer av klinisk praksis
      Vis alle løsninger
    • Skatt og Økonomi

      Vi hjelper skatte- og regnskapseksperter og -bedrifter av alle størrelser med å øke produktivitet, navigere gjennom endringer og levere bedre resultater. Ved å benytte arbeidsflyter som er optimalisert ved hjelp av teknologi og veiledet av dyp domeneekspertise, hjelper vi organisasjoner med å vokse, administrere og beskytte deres forretninger og deres kunders forretninger.

      Oversikt over Skatt og Økonomi
      Løsninger
      • Skatt & Økonomi NorgeKomplette løsninger både for profesjonelle brukere og rådgivere
      • Capego ÅrsoppgjørSkandinavias ledende skybaserte årsoppgjørprogram
      • Capego SmartSignDigital og effektiv signering
      • BlueWhale Sikker E-postSend sikre e-poster
      Vis alle løsninger
      Trender
      • Kunstig intelligens (AI) i skat og regnskab
      Ekspertinnsikt
      • Reduser risikoen med en ISO 27001-sertifisert leverandør
      • Endringer i krav til bærekraftsrapportering i årsberetningen
      • Tips og strategier for administrerende direktører i regnskapsbyråer
      • Slik kan du bruke Business Intelligence til forretningsanalyse
      Vis all ekspertinnsikt
    • ESG

      Tilbyr omfattende verktøy og ekspertveiledning til selskaper for å bidra til å oppfylle reguleringskrav for å støtte bærekraftarbeid og håndtere ESG-risikoer effektivt.

      Oversikt over ESG
      Løsninger
      • CCH TagetikEnhetlig programvare for ytelsesstyring
      • OneSumX for Finance, Risk and Regulatory ReportingOppdag vår løsning for klimarisiko og reguleringskrav i tråd med ESG
      • TeamMateLøsninger for revisorer
      • EnablonProgramvareløsninger for risiko og forskriftssamsvar, engineering og drift, og HMS og bærekraft
      Vis alle løsninger
    • Finans

      Løsningene våre for finanssektoren hjelper kunder med å oppfylle sine forpliktelser overfor myndighetene. Vi spesialiserer oss på å samle og optimalisere prosesser for å levere en nøyaktig og aktuell oversikt over den finansielle situasjon i sanntid.

      Oversikt over finans
      Løsninger
      • CCH TagetikEnhetlig programvare for ytelsesstyring
      • OneSumX Finance, Risk & Reguatory Reporting Integrert regulatorisk overensstemmelse og rapporteringsløsning
      Vis alle løsninger
    • Forskriftssamsvar

      Vi hjelper organisasjoner med samsvar med stadig skiftende lovpålagte forskrifter, risikohåndtering, økt effektivitet og til å oppnå bedre forretningsresultater.

      Oversikt over forskriftssamsvar
      Løsninger
      • OneSumX for Finance, Risk and Regulatory ReportingIntegrert regulatorisk overensstemmelse og rapporteringsløsning
      • EnablonProgramvareløsninger for risiko og forskriftssamsvar, engineering og drift, og HMS og bærekraft
      Vis alle løsninger
    • Juridisk
    1. Tilbake til Hjem >
    2. Tilbake til Løsninger fra Wolters Kluwer >
    3. Tilbake til Lippincott Journals >
    4. Tilbake til Lippincott Open Access >
    5. Frequently asked questions

    Frequently Asked Questions About Open Access

    View some common questions about open access, the difference between that and free, what the Creative Commons License is, and much more.
    Secondary Navigation
    Lippincott Journals
    • Authors
    • Editor Resources
    • Editorial Supplements
    • Wolters Kluwer Open Access

      Open access is the free, immediate online access for any user to digital scientific and scholarly material, primarily research articles published in peer‐reviewed journals.

      Learn more
      Open Access
      • Overview
      • About Us
      • Publish
      • Partner
      • Funders and Institutions’ Mandates
      • Journals
      • Frequently Asked Questions
    • Society Services
    • News From Our Journals
    • Advertisers
    • Support
    Shop Our Journals
    • What is open access?

      The free, immediate, online access, for any user, web‐wide, to digital scientific and scholarly material, primarily research articles published in peer‐reviewed journals.

    • What is the hybrid model?

      The hybrid model is when a journal has a combination of open access and subscription articles. Authors have a choice to pay a fee for the article to be immediately accessible online. The author retains copyright of the article. Open Access articles are subject to the same peer review process as any article within that journal.

    • What is the gold model?

      The gold model refers to journals that are fully Open Access and no subscription is required to access them. All articles published in one of our gold open access journals are freely available to readers. There is no subscription fee to read and access content and articles are made available under the terms of a Creative Commons license. Most of our gold journals allow the authors to choose one of several CC licenses including CC BY.

    • Are the peer review and production processes the same for open access articles?

      Yes, the peer review and production processes are the same for the open access articles in the hybrid model as they are for those articles published and accessible by subscription or pay per view.

    • How does the journal ensure that the peer review process isn’t biased?

      All articles undergo the journal’s standard peer review process. Authors are given the option to make an article open access only after the article has been returned for revisions or accepted.

    • When will an author be given a choice to publish a paper open access?

      Authors will have the option to publish their paper as open access after the article has been sent back for revisions, and acceptance.

    • Who can request an article to be open access?

      Only the author of the manuscript can request an article to be open access. Funders of the published work may request open access with express written permission from the author.

    • How will I know if an article is open access?

      LWW articles that are open access have the open icon next to them.

    • Should authors still sign the Copyright Transfer Agreement?

      Upon submission the author will sign the journal’s standard copyright transfer agreement (CTA). The CTA contains text that states that if the article is accepted, and the author chooses the open access option, the author will be required to sign a License to Publish and upload this form to the journal’s manuscript submission system. The article will then be published under the terms of the Creative Commons License Attribution‐Noncommerical No Derivative 4.0 or for articles funded by recognized funding bodies and institutions, under the terms of the Attribution 4.0 (CC BY) license.

    • What is a Creative Commons License?

      Open access articles will be freely available to read, download and share from the time of publication. All open access articles are published under the terms of various Creative Commons 4.0 licenses as defined below:

      • Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): This license is the most restrictive of the six main licenses, only allowing others to download the works and share it with others as long as they credit the original journal and author, but they can’t change the work in any way or use it commercially.
      • Attribution-NonCommerical-ShareAlike (CC BY-NC-SA): This license lets others remix, tweak, and build upon the work noncommercially, as long as they credit the original journal and author and license their new creations under the identical terms.
      • Attribution-NonCommercial (CC BY-NC): This license lets others remix, tweak, and build upon the work noncommercially, and although their new works must also acknowledge the original journal and author and be noncommercial, they don’t have to license their derivative works on the same terms.
      • Attribution-NoDerivs (CC BY-ND): This license allows for redistribution, commercial and noncommercial, of the work as long as it is passed along unchanged and in whole, with credit to the original journal and author.
      • Attribution-ShareAlike (CC BY-SA): This license lets others remix, tweak, and build upon the work even for commercial purposes, as long as they credit the original journal and author and license their new creations under the identical terms. All new works based on the original will carry the same license, so any derivatives will also allow commercial use.
      • Attribution (CC BY): This license lets others distribute, remix, tweak, and build upon the work, even commercially, as long as they credit the journal and author for the original creation. This is the most accommodating of licenses offered.
    • Can Open Access articles be posted to personal website or institutional repositories?

      Yes, the Creative Commons license allows this.

    • Will open access articles be indexed in the same manner as the non‐open access articles in the journal?

      Yes. If an author chooses to publish their accepted article as open access, the article is still a part of the regular journal issue and will be included in the same abstracting and indexing services the journal is covered in regularly.

    • Will open access articles be deposited in PubMedCentral?

      For hybrid open access articles published in journals that are indexed in MEDLINE or who are funded in whole or in part by the National Institutes of Health, the final, published version of the article will be deposited into PubMed Central by Wolters Kluwer.

    • What is the difference between free and open access?

      ‘Free’ is generic, for any content at no cost, like a website, YouTube videos, free abstracts, or articles that are made free for promotion. Though the content is free to read, reuse and sharing is limited by standard copyright and licensing restrictions that applies to all non-open access content. ‘Open access’ content is free permanently on all online locations and allows users to link, read, download, store, use, and data-mine the digital content of that article without copyright or licensing restrictions. The open access licenses (the Creative Commons licenses detailed above) set some restrictions on commercial and derivative uses of open access content.

    • What is the difference between open access and NIH Public Access Policy or funders’ public access policies?

      A number of research funding agencies now require or request authors to submit the post‐print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW identifies to the National Library of Medicine (NLM) articles that require deposit and transmits the post‐print of an article based on research funded in whole or in part by the National Institutes of Health to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. LWW ensures that authors can fully comply with the public access requirements of major funding bodies worldwide. Additionally, all authors who choose the open access option will have their final published article deposited into PubMed Central provided the journal is indexed by MEDLINE.

    • Does Wolters Kluwer support the recent open access mandates?

      Yes, Wolters Kluwer hybrid open access program provides authors with a means to comply with open access mandates and meet applicable license requirements. Open access articles will be made available under the terms of the Creative Commons License and the final version of the article will be deposited to PubMed Central on publication provided the journal is indexed in MEDLINE or is funded in whole or in part by the National Institutes of Health.

    • My article has already been published; can I make it open access?

      Authors who would like to make their previously published article open access should contact the journal editorial office for more information.

    • Are open access articles published ahead of print?

      Yes, open access articles can be published ahead of print.

    • I have other questions, who can I speak with?

      For any questions, please contact your editorial office or Publisher.

    • What article types may be made open access in journals in the hybrid model?

      In general, only original research including case reports and reviews will be made open access under this option. Please consult the specific journal’s Instruction for Authors for more information.

    • What Wolters Kluwer journals are included in the hybrid model?

      View a list of journals that include the hybrid option.

    • What is an article processing charge?

      The article processing charge (APC) is a payment that allows the article to be freely available online in perpetuity. The costs cover peer‐review, copy‐editing, hosting, and promotion of the article. An APC can be paid for by the funder, author, institution, or a sponsor. Additional page and color charges apply on some hybrid journals. The article processing charges vary for different titles for a variety of factors such as the size of the journal, volume of submissions, etc. View the complete list of APC charges.

    • How do authors pay the article processing charge (APC)?

      Wolters Kluwer will provide authors with a link and instructions on how to pay via our online payment portal.

    • Can institutions or other third parties pay on an author’s behalf?

      Yes, authors can pay by credit card or they can request an invoice to be sent to their institution and third parties. Authors can also forward the payment link we provide to these other parties.

    • How do I know if my institution participates in read-and-publish deals allowing me to request funding for an APC?

      Wolters Kluwer currently has read-and-publish agreements with institutional consortia listed here.

      Corresponding authors who are affiliated with the participating institution and who qualify as eligible authors* can publish their articles open access in the eligible LWW journals at no direct cost to them. To qualify for the APC waiver, the corresponding author must provide their participating institution’s name and institutional email address in the journal’s submission system. On acceptance, the corresponding author will be asked to place an open access order in the publisher’s payment portal where they will be able to request the APC be funded in accordance with this agreement. A $0.00 APC will then be applied.

      Authors can choose to publish under the Creative Commons Attribution License (CC BY) where offered or the Creative Commons Attribution Non-Commercial Non-Derivative License (CC BY-NC-ND).

      *Eligible authors: Corresponding authors who are teaching and research staff employed by or otherwise accredited to one of the participating institutions as well as students enrolled or accredited to one of the institutions and who want to publish open access articles.

    Subscribe to author communications
    Footer Navigation
    • Om Wolters Kluwer
    • Nyheter og pressemeldinger
    • Arrangementer
    • Løsninger
    • Helse
    • Skatt og økonomi
    • ESG
    • Finans
    • Forskriftssamsvar
    • Juridisk
    • Ekspertinnsikt
    • Karrierer
    • Investorer
    • Områdekart
    • Site Owner
    Follow Wolters Kluwer
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube
    Wolters Kluwer Logo

    When you have to be right

    • Vilkår for bruk
    • Personvern og informasjonskapsler
    • Dine personvernsalternativer i California
      Your California privacy Choices

    © 2025 Wolters Kluwer N.V. og/eller deres datterselskaper. Med enerett.

    Back To Top